BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26956593)

  • 21. Comparison of Two Approaches for the Attachment of a Drug to Gold Nanoparticles and Their Anticancer Activities.
    Fu Y; Feng Q; Chen Y; Shen Y; Su Q; Zhang Y; Zhou X; Cheng Y
    Mol Pharm; 2016 Sep; 13(9):3308-17. PubMed ID: 27518201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel.
    Zhang P; Wang C; Zhao J; Xiao A; Shen Q; Li L; Li J; Zhang J; Min Q; Chen J; Chen HY; Zhu JJ
    ACS Nano; 2016 Mar; 10(3):3637-47. PubMed ID: 26905935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
    Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
    J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NIR-/pH-Responsive drug delivery of functionalized single-walled carbon nanotubes for potential application in cancer chemo-photothermal therapy.
    Wang L; Shi J; Jia X; Liu R; Wang H; Wang Z; Li L; Zhang J; Zhang C; Zhang Z
    Pharm Res; 2013 Nov; 30(11):2757-71. PubMed ID: 23765399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
    Zhang C; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
    Sci Rep; 2020 Dec; 10(1):22015. PubMed ID: 33328545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybridized doxorubicin-Au nanospheres exhibit enhanced near-infrared surface plasmon absorption for photothermal therapy applications.
    Zhou J; Wang Z; Li Q; Liu F; Du Y; Yuan H; Hu F; Wei Y; You J
    Nanoscale; 2015 Mar; 7(13):5869-83. PubMed ID: 25757809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxorubicin-loaded NaYF4:Yb/Tm-TiO2 inorganic photosensitizers for NIR-triggered photodynamic therapy and enhanced chemotherapy in drug-resistant breast cancers.
    Zeng L; Pan Y; Tian Y; Wang X; Ren W; Wang S; Lu G; Wu A
    Biomaterials; 2015 Jul; 57():93-106. PubMed ID: 25913254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NIR-cleavable drug adducts of gold nanostars for overcoming multidrug-resistant tumors.
    Del Valle AC; Su CK; Sun YC; Huang YF
    Biomater Sci; 2020 Mar; 8(7):1934-1950. PubMed ID: 32039412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional Chitosan-Capped Gold Nanoparticles for enhanced cancer chemo-radiotherapy: An invitro study.
    Fathy MM; Mohamed FS; Elbialy N; Elshemey WM
    Phys Med; 2018 Apr; 48():76-83. PubMed ID: 29728233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEGylated PAMAM dendrimer-doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy.
    Li X; Takashima M; Yuba E; Harada A; Kono K
    Biomaterials; 2014 Aug; 35(24):6576-84. PubMed ID: 24816361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and evaluation of pH-sensitive immunoliposomes for enhanced delivery of anticancer drug to ErbB2 over-expressing breast cancer cells.
    Li T; Amari T; Semba K; Yamamoto T; Takeoka S
    Nanomedicine; 2017 Apr; 13(3):1219-1227. PubMed ID: 27965166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle.
    Zhou Z; Kennell C; Jafari M; Lee JY; Ruiz-Torres SJ; Waltz SE; Lee JH
    Int J Pharm; 2017 Sep; 530(1-2):300-307. PubMed ID: 28778627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellularly Acid-Switchable Multifunctional Micelles for Combinational Photo/Chemotherapy of the Drug-Resistant Tumor.
    Wang T; Wang D; Yu H; Wang M; Liu J; Feng B; Zhou F; Yin Q; Zhang Z; Huang Y; Li Y
    ACS Nano; 2016 Mar; 10(3):3496-508. PubMed ID: 26866752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
    Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
    J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Near-infrared light-triggered thermochemotherapy of cancer using a polymer-gold nanorod conjugate.
    Ko H; Son S; Bae S; Kim JH; Yi GR; Park JH
    Nanotechnology; 2016 Apr; 27(17):175102. PubMed ID: 26987360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
    Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
    Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near infrared light responsive hybrid nanoparticles for synergistic therapy.
    Liang Y; Gao W; Peng X; Deng X; Sun C; Wu H; He B
    Biomaterials; 2016 Sep; 100():76-90. PubMed ID: 27244691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods.
    Wang D; Xu Z; Yu H; Chen X; Feng B; Cui Z; Lin B; Yin Q; Zhang Z; Chen C; Wang J; Zhang W; Li Y
    Biomaterials; 2014 Sep; 35(29):8374-84. PubMed ID: 24996756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A polyoxyethylene sorbitan oleate modified hollow gold nanoparticle system to escape macrophage phagocytosis designed for triple combination lung cancer therapy via LDL-R mediated endocytosis.
    Shen Y; Xia Y; Yang E; Ye Z; Ding Y; Tu J; Zhang Y; Xu P
    Drug Deliv; 2020 Dec; 27(1):1342-1359. PubMed ID: 32964732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.